)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Fortress Biotech
Fortress Biotech (FBIO) investor relations material
Fortress Biotech Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary1 Jul, 2026
Market position and financial highlights
Commercial-stage pharmaceutical company focused on proprietary dermatology products in a $5.8B market, with 2025 net product revenues of $61M and adjusted EBITDA of $2.9M.
Market cap of $195M, 27.5M shares outstanding, and $24.1M in cash as of 12/31/2025.
DERM stock added to the Russell 2000 & 3000 indexes in June 2025.
Leadership and commercial infrastructure
Senior management team with decades of dermatology and pharmaceutical experience, including key roles at Medicis and Bausch Health.
Sales force averages 9 years of dermatology experience, with 280 years combined, covering 87% of oral rosacea prescriptions.
Unique incentive programs and equity rewards drive sales performance.
Product portfolio and growth drivers
Five core dermatology brands, with Emrosi® as the key growth driver, launched April 2025.
Emrosi® demonstrated head-to-head superiority over Oracea® in Phase 3 trials and is positioned to become the new standard of care for rosacea.
Other brands include Qbrexza, Amzeeq, Accutane, and Fzilxi, targeting acne, rosacea, and hyperhidrosis.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Fortress Biotech
- Directors and auditors for 2026 were approved by shareholders, concluding the meeting.FBIO
AGM 202617 Jun 2026 - Two FDA approvals and a major acquisition highlight Fortress Biotech's transformative 2024.FBIOQ4 202411 Jun 2026
- Three FDA approvals, strong revenue, and a robust late-stage pipeline drive near-term growth.FBIOCorporate presentation11 Jun 2026
- Q1 2026 net income jumped to $108.4M on a $205M PRV sale and 21–22% revenue growth.FBIOQ1 202626 May 2026
- Scalable, royalty-driven model and recent monetizations fuel growth and strengthen financial position.FBIOA.G.P.'s Annual Virtual Healthcare Conference20 May 2026
- Shareholders will vote virtually on director elections, auditor ratification, and equity-based executive pay.FBIOProxy filing29 Apr 2026
- Virtual vote set for June 2026 on director elections and auditor ratification.FBIOProxy filing29 Apr 2026
- Three FDA approvals, major asset monetizations, and a robust pipeline drive near-term growth.FBIOCorporate presentation22 Apr 2026
- Revenue rose 10% to $63.3M, with improved margins and major asset sales boosting liquidity.FBIOQ4 202531 Mar 2026
Next Fortress Biotech earnings date
Q2 202613 Aug, 2026
Fortress Biotech
Next Fortress Biotech earnings date
Q2 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage